Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Raytheon Technologies Corp (RTX) vs Smith & Nephew plc (SNN) Price & Performance

Raytheon Technologies CorpTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Raytheon Technologies Corp vs Smith & Nephew plc — how do they compare? Raytheon Technologies Corp trades at $193.82 (market cap $261.85B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Raytheon Technologies Corp is far larger — about 20.7× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.57%). Which is the better fit depends on your goals.

RTXSNN
Market Cap
$261.85B$12.64B
Sector
IndustrialsHealth
52-Week High
$212.16$38.70
52-Week Low
$149.17$28.73
Enterprise Value
$293.97B$15.41B
Dividend Yield
1.5%2.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Raytheon Technologies Corp

RTX trades at $193.51, down 0.44% today, with a bullish technical signal and strong analyst support. Recent contract wins, including a $515 million Navy radar deal (PRNewsWire, June 3, 2026), and earnings beats in Q4 2025 and Q1 2026 highlight operational momentum. Revenue growth accelerated to $88.6 billion in 2025, with net income margin improving to 8.03%. The stock faces resistance near $196-$199, with support at $192.

The outlook remains positive given defense spending tailwinds and production expansions, but elevated P/E of 36.48 poses valuation risk. Analysts project 10% upside to a $213 consensus target, with no sell ratings. Key risks include debt levels and geopolitical volatility affecting contracts.

Smith & Nephew plc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Raytheon Technologies Corp

Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.

Read more on RTX

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN